SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported):
June 13, 1997
________________________________________
THERMO CARDIOSYSTEMS INC.
(Exact name of Registrant as specified in its charter)
Massachusetts 1-10114 04-3027040
(State or other (Commission (I.R.S. Employer
jurisdiction of File Number) Identification Number)
incorporation or
organization)
470 Wildwood Street
P. O. Box 2697
Woburn, Massachusetts 01888-2697
(Address of principal executive offices) (Zip Code)
(617) 622-1000
(Registrant's telephone number
including area code)
PAGE
<PAGE>
Item 5. Other Events
------------
On June 13, 1997, Thermo Cardiosystems Inc. (the "Company") announced
that its board of directors has authorized the repurchase, through June 12,
1998, of up to $20,000,000 of its own common stock in the open market, or
in negotiated transactions. The Company will repurchase such shares when
they are available at prices the Company considers attractive.
Item 7. Financial Statements, Pro Forma Combined Condensed Financial
------------------------------------------------------------
Information and Exhibits
------------------------
(a) Financial Statements of Business Acquired: not applicable.
(b) Pro Forma Combined Condensed Financial Information: not
applicable.
(c) Exhibits
99 Press Release of the Company, dated June 13, 1997
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized, on this 13th day of June, 1997.
THERMO CARDIOSYSTEMS INC.
By: /s/ Jonathan W. Painter
-----------------------
Jonathan W. Painter
Treasurer
EXHIBIT 99
Investor Contact: 617-622-1111
Media Contact: 617-622-1252
THERMO CARDIOSYSTEMS TO BUY ITS OWN COMMON STOCK
WOBURN, Mass., June 13, 1997 -- Thermo Cardiosystems Inc.
(ASE-TCA) announced today that its board of directors has
authorized the repurchase, through June 12, 1998, of up to $20
million of its own common stock in the open market, or in
negotiated transactions. Thermo Cardiosystems will repurchase
such shares when they are available at prices the company
considers attractive.
Thermo Cardiosystems Inc. is a leader in the research,
development, and manufacture of implantable left
ventricular-assist systems (LVAS). Its HeartMate(R) device, is
implanted alongside the natural heart and is designed to take
over the pumping function of the left ventricle for patients
whose hearts are too damaged or diseased to beat adequately on
their own. The company's air-driven LVAS is the only implantable
heart-assist device approved for commercial sale in the United
States. Thermo Cardiosystems is a public subsidiary of Thermedics
Inc., a Thermo Electron company.
# # #
AA971640011
